Albert David Ltd.

•

albertdavidindia.comBSE: 524075NSE: ALBERTDAVD

Market Cap₹ 499 Cr.

Current Price

High / Low₹ 932 / 580

Stock P/E22.1

Book Value₹ 742

Price to Book0.86

Dividend Yield0.57 %

ROCE0.8 %

ROE-0.4 %

Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company is almost debt free
Latest quarter profit grew 303.0% YoY, showing strong momentum
Company has a consistent dividend-paying track record

CONS

Company is loss-making at the operating / net level
A large part of profit comes from other income (1419.9% of PBT)
Operating cash flow has been negative in recent years
Receivables are growing faster than sales - a possible quality concern
Company has a low return on equity of 8.6% over last 3 years
Interest coverage is weak at 1.2x - earnings barely cover interest

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SUNPHARMA	1933.00	38.34	463791.45	0.83	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9232.00	83.79	245080.59	0.33	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	5004.40	87.28	190351.29	0.76	566.00	3.28	4921.00	57.32	19.27	33.81
4.	ZYDUSLIFE	1151.20	25.44	114832.64	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
5.	CIPLA	1413.15	33.87	114162.52	0.92	785.55	-39.18	7119.28	4.13	16.00	16.73
6.	LAURUSLABS	1863.00	92.06	100660.17	0.11	362.07	123.94	2026.31	29.10	18.20	31.50
7.	LUPIN	2152.60	17.80	98431.05	0.84	1416.98	16.01	8276.89	34.28	28.86	29.59
8.	MANKIND	2380.00	48.13	98304.73	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
9.	DRREDDY	1161.00	30.07	96906.34	0.69	435.60	-69.10	8099.80	-5.21	13.75	10.63
10.	AUROPHARMA	1656.30	25.67	95299.84	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
11.	GLENMARK	2451.70	38.49	69193.02	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	ALBERTDAVD	874.00	22.11	498.81	0.57	32.00	303.00	101.34	43.60	0.83	10.49

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	92	93	88	89	89	98	83	75	71	87	90	86	101
	79	77	80	79	88	92	82	80	81	85	79	83	94
Operating Profit	13	16	8	10	1	6	1	-5	-11	3	11	3	11
OPM %	14.13%	17.14%	9.47%	10.75%	0.98%	6.32%	0.82%	-6.34%	-15.09%	2.91%	12.03%	3.21%	10.49%
Other Income	18	12	17	10	23	21	-9	-5	22	-2	12	-25	28
Interest	0	0	0	0	0	0	0	0	1	1	1	0	1
Depreciation	2	1	2	2	2	2	2	2	2	2	2	3	2
	29	27	23	18	22	25	-10	-12	8	-3	20	-25	36
Tax %	19.53%	23.54%	20.14%	28.71%	14.60%	28.09%	7.58%	12.53%	5.92%	-27.91%	23.12%	15.06%	10.61%
Net Profit	23	20	19	13	19	18	-9	-10	8	-3	15	-21	32
	41	36	33	23	33	32	-16	-18	14	-6	27	-38	6
Equity Capital	6	6	6	6	6	6	6	6	6	6	6	6	6
Reserves	0	0	0	0	0	0	0	0	0	0	0	0	0
Promoter Pledge %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	295	290	317	321	247	314	342	362	346	334	364
	277	275	288	290	228	273	297	315	343	328	340
Operating Profit	34	25	51	38	36	57	60	105	33	13	—
OPM %	11	9	16	12	15	18	18	29	9	4	—
Other Income	16	10	21	7	17	16	15	58	30	7	13
Interest	1	1	1	1	1	1	1	0	1	3	3
Depreciation	8	8	7	8	8	9	9	7	7	10	10
	26	16	43	29	27	47	51	97	25	1	28
Tax %	38	38	38	34	19	25	29	22	32	385	19
Net Profit	16	10	27	19	22	35	36	75	17	-1	23
EPS	0	0	0	0	39	62	63	132	30	-3	—
Dividend Payout %	20	32	13	21	15	15	14	9	17	-191	—
Minority Interest	0	0	0	0	0	0	0	0	0	0	0
Share of Associates	0	0	0	0	0	0	0	0	0	0	0
Adjusted EPS	28	17	47	34	39	62	63	132	30	-3	—

COMPOUNDED SALES GROWTH

10 Years:: 0%
5 Years:: 6%
3 Years:: -1%

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: —
3 Years:: —

STOCK PRICE CAGR

10 Years:: 11%
5 Years:: 8%
3 Years:: 3%
1 Year:: 9%

RETURN ON EQUITY

10 Years:: 10%
5 Years:: 10%
3 Years:: 9%
Last Year:: 0%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
LIABILITIES	-	-	-	-	-	-	-	-	-	-
Equity Capital	6	6	6	6	6	6	6	6	6	6
	177	180	205	217	239	274	306	377	387	386
	30	28	0	0	0	4	4	2	10	28
Trade Payables	27	32	30	38	25	30	32	34	38	33
	110	116	135	137	136	161	165	185	184	184
Total Liabilities	351	361	376	398	405	475	512	604	625	637
ASSETS	-	-	-	-	-	-	-	-	-	-
	87	83	77	91	84	88	80	83	99	100
Capital Work in Progress	7	3	3	2	1	1	3	7	2	21
	59	68	113	122	138	183	193	273	260	243
	51	43	44	43	36	39	51	44	64	58
	0	0	0	0	0	0	0	29	27	34
Cash & Bank	15	26	7	7	35	19	25	31	2	33
	133	138	132	134	112	146	161	137	171	148
Total Assets	351	361	376	398	405	475	512	604	625	637
Total Debt	30	28	0	2	2	5	5	2	10	28
Net Working Capital	76	83	117	120	142	146	205	273	250	259
Contingent Liabilities	38	5	3	4	4	2	2	5	5	5
Book Value per Share	320.67	325.81	368.74	390.38	428.20	489.68	545.93	671.05	687.70	686.04
Face Value	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	20	30	32	30	37	40	11	46	-28	-8
Cash from Investing	-37	-11	-19	-20	-39	-40	-5	-33	23	-4
Cash from Financing	7	-5	-17	-10	-2	-2	-6	-8	0	12
	-10	14	-4	-0	-4	-1	-1	4	-5	-0
Free Cash Flow	-33	30	32	12	37	29	10	33	-43	-35
OCF / Net Profit	1.25	3.05	1.20	1.58	1.65	1.15	0.29	0.60	-1.65	5.12
Cumulative 5-Year FCF	0	0	0	0	77	139	119	120	65	-7

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
PER SHARE
EPS (₹)	27.96	17.24	46.68	33.59	38.80	61.78	63.38	132.15	30.14	-2.62
Book Value (₹)	320.67	325.81	368.74	390.38	428.20	489.68	545.93	671.05	687.70	686.04
Dividend per Share (₹)	5.50	5.50	6.00	7.00	6.00	9.00	9.00	11.50	5.00	5.00
Cash EPS (₹)	41.13	31.91	58.97	47.03	53.22	77.21	78.36	144.11	42.35	14.49
PROFITABILITY
Operating Margin %	11.08%	8.16%	15.22%	11.14%	14.00%	17.17%	16.60%	12.25%	0.85%	1.62%
Net Margin %	5.21%	3.17%	7.99%	5.68%	8.50%	10.66%	10.03%	19.67%	4.63%	-0.42%
ROE %	9.98%	5.33%	13.44%	8.85%	9.48%	13.46%	12.24%	21.72%	4.44%	-0.38%
ROCE %	14.29%	7.94%	20.60%	13.74%	11.99%	18.10%	17.10%	27.87%	6.54%	0.83%
	5.18%	2.77%	7.23%	4.95%	5.51%	8.01%	7.33%	13.51%	2.80%	-0.24%
EFFICIENCY
Debtor Days	41	36	27	28	35	25	28	28	28	32
Inventory Days	59	55	48	47	55	41	45	45	53	63
Payable Days	166	181	149	167	165	115	131	133	112	112
	-67	-90	-75	-92	-75	-49	-57	-59	-32	-18
FINANCIAL HEALTH
Debt to Equity (x)	0.16x	0.15x	0.00x	0.01x	0.01x	0.02x	0.02x	0.01x	0.03x	0.07x
Interest Coverage (x)	29.37x	16.73x	50.78x	30.41x	36.00x	71.35x	87.91x	226.30x	47.11x	1.18x
	1.48x	1.52x	1.81x	1.81x	2.05x	1.81x	2.09x	2.33x	2.15x	2.11x
GROWTH
Revenue Growth %	-8.46%	-1.69%	9.25%	1.13%	-22.86%	26.70%	8.95%	6.12%	-4.61%	-3.52%
Operating Profit Growth %	2.10%	-25.47%	100.45%	-25.87%	-3.07%	55.72%	5.45%	74.62%	-68.68%	-59.71%
Net Profit Growth %	-66.76%	-38.32%	170.71%	-28.05%	15.52%	59.23%	2.60%	108.49%	-77.19%	-108.69%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	108.49%	-77.19%	-108.69%
VALUATION
P/E (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	8.14x	26.92x	0.00x
P/B (x)	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	1.60x	1.18x	0.86x
Dividend Yield %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	1.07%	0.62%	0.85%
	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	5.59x	14.40x	25.07x

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	62.13	62.13	62.13	62.24	62.24	62.24	62.24	62.24	62.24
	0.80	0.88	0.86	1.00	0.84	0.60	0.60	0.58	0.57
	1.67	1.63	1.63	1.64	1.65	1.65	1.65	1.65	1.63
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	35.40	35.35	35.37	35.11	35.26	35.50	35.50	35.52	35.56

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-08-29

Shareholders meeting

2026-08-29 - Albert David Limited has informed the Exchange with copy of minutes of Annual General Meeting held on August 06, 2026

2026-08-07

Shareholders meeting

2026-08-07 - Albert David Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 06, 2026. Further, the company has informed the Exchange regarding voting results.

2026-08-07

Copy of Newspaper Publication

2026-08-07 - Albert David Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-07

Shareholders meeting

2026-08-07 - Albert David Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 06, 2026

2026-08-06

Resignation of Director/KMP/SMP

2026-08-06 - Albert David Limited has informed the Exchange about Resignation of Director/KMP/SMP

2026-08-06

Change in Management

2026-08-06 - Albert David Limited has informed the Exchange about change in Management

2026-08-06

Resignation of Director/KMP/SMP

2026-08-06 - Albert David Limited has informed the Exchange about Resignation of Director/KMP/SMP

2026-08-06

Outcome of Board Meeting

2026-08-06 - Albert David Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

2026-07-28

Copy of Newspaper Publication

2026-07-28 - Albert David Limited has informed the Exchange about Copy of Newspaper Publication

News

Recent coverage and analyst commentary for ALBERTDAVD

Loading news…

🤖

AI Stock Analyst

Albert David Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

SUNPHARMA

1933.00

38.34

463791.45

0.83

2901.23

26.53

15299.88

10.98

19.11

28.81

DIVISLAB

9232.00

83.79

245080.59

0.33

902.00

65.50

3080.00

27.80

21.51

40.75

TORNTPHARM

5004.40

87.28

190351.29

0.76

566.00

3.28

4921.00

57.32

19.27

33.81

ZYDUSLIFE

1151.20

25.44

114832.64

0.09

990.20

-34.90

8017.00

23.97

21.39

24.54

CIPLA

1413.15

33.87

114162.52

0.92

785.55

-39.18

7119.28

4.13

16.00

16.73

LAURUSLABS

1863.00

92.06

100660.17

0.11

362.07

123.94

2026.31

29.10

18.20

31.50

LUPIN

2152.60

17.80

98431.05

0.84

1416.98

16.01

8276.89

34.28

28.86

29.59

MANKIND

2380.00

48.13

98304.73

0.04

574.09

29.12

4030.59

12.89

13.24

26.30

DRREDDY

1161.00

30.07

96906.34

0.69

435.60

-69.10

8099.80

-5.21

13.75

10.63

AUROPHARMA

1656.30

25.67

95299.84

0.24

1032.03

25.22

9150.35

17.44

12.76

20.54

GLENMARK

2451.70

38.49

69193.02

0.10

482.83

927.88

4018.48

31.35

20.35

20.03

ALBERTDAVD

874.00

22.11

498.81

0.57

32.00

303.00

101.34

43.60

0.83

10.49

Jun 2023

Sep 2023

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

101

Operating Profit

-5

-11

OPM %

14.13%

17.14%

9.47%

10.75%

0.98%

6.32%

0.82%

-6.34%

-15.09%

2.91%

12.03%

3.21%

10.49%

Other Income

-9

-5

-2

-25

Interest

Depreciation

-10

-12

-3

-25

Tax %

19.53%

23.54%

20.14%

28.71%

14.60%

28.09%

7.58%

12.53%

5.92%

-27.91%

23.12%

15.06%

10.61%

Net Profit

-9

-10

-3

-21

-16

-18

-6

-38

Equity Capital

Reserves

Promoter Pledge %

0.00%

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

TTM

295

290

317

321

247

314

342

362

346

334

364

277

275

288

290

228

273

297

315

343

328

340

Operating Profit

105

—

OPM %

—

Other Income

Interest

Depreciation

Tax %

385

Net Profit

-1

EPS

132

-3

—

Dividend Payout %

-191

—

Minority Interest

Share of Associates

Adjusted EPS

132

-3

—

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

LIABILITIES

Equity Capital

177

180

205

217

239

274

306

377

387

386

Trade Payables

110

116

135

137

136

161

165

185

184

Total Liabilities

351

361

376

398

405

475

512

604

625

637

ASSETS

100

Capital Work in Progress

113

122

138

183

193

273

260

243

Cash & Bank

133

138

132

134

112

146

161

137

171

148

Total Assets

351

361

376

398

405

475

512

604

625

637

Total Debt

Net Working Capital

117

120

142

146

205

273

250

259

Contingent Liabilities

Book Value per Share

320.67

325.81

368.74

390.38

428.20

489.68

545.93

671.05

687.70

686.04

Face Value

10.00

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

-28

-8

Cash from Investing

-37

-11

-19

-20

-39

-40

-5

-33

-4

Cash from Financing

-5

-17

-10

-2

-6

-8

-10

-4

-0

-4

-1

-5

-0

Free Cash Flow

-33

-43

-35

OCF / Net Profit

1.25

3.05

1.20

1.58

1.65

1.15

0.29

0.60

-1.65

5.12

Cumulative 5-Year FCF

139

119

120

-7

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

PER SHARE

EPS (₹)

27.96

17.24

46.68

33.59

38.80

61.78

63.38

132.15

30.14

-2.62

Book Value (₹)

320.67

325.81

368.74

390.38

428.20

489.68

545.93

671.05

687.70

686.04

Dividend per Share (₹)

5.50

6.00

7.00

6.00

9.00

11.50

5.00

Cash EPS (₹)

41.13

31.91

58.97

47.03

53.22

77.21

78.36

144.11

42.35

14.49

PROFITABILITY

Operating Margin %

11.08%

8.16%

15.22%

11.14%

14.00%

17.17%

16.60%

12.25%

0.85%

1.62%

Net Margin %

5.21%

3.17%

7.99%

5.68%

8.50%

10.66%

10.03%

19.67%

4.63%

-0.42%

ROE %

9.98%

5.33%

13.44%

8.85%

9.48%

13.46%

12.24%

21.72%

4.44%

-0.38%

ROCE %

14.29%

7.94%

20.60%

13.74%

11.99%

18.10%

17.10%

27.87%

6.54%

0.83%

5.18%

2.77%

7.23%

4.95%

5.51%

8.01%

7.33%

13.51%

2.80%

-0.24%

EFFICIENCY

Debtor Days

Inventory Days

Payable Days

166

181

149

167

165

115

131

133

112

-67

-90

-75

-92

-75

-49

-57

-59

-32

-18

FINANCIAL HEALTH

Debt to Equity (x)

0.16x

0.15x

0.00x

0.01x

0.02x

0.01x

0.03x

0.07x

Interest Coverage (x)

29.37x

16.73x

50.78x

30.41x

36.00x

71.35x

87.91x

226.30x

47.11x

1.18x

1.48x

1.52x

1.81x

2.05x

1.81x

2.09x

2.33x

2.15x

2.11x

GROWTH

Revenue Growth %

-8.46%

-1.69%

9.25%

1.13%

-22.86%

26.70%

8.95%

6.12%

-4.61%

-3.52%

Operating Profit Growth %

2.10%

-25.47%

100.45%

-25.87%

-3.07%

55.72%

5.45%

74.62%

-68.68%

-59.71%

Net Profit Growth %

-66.76%

-38.32%

170.71%

-28.05%

15.52%

59.23%

2.60%

108.49%

-77.19%

-108.69%

0.00%

108.49%

-77.19%

-108.69%

VALUATION

P/E (x)

0.00x

8.14x

26.92x

0.00x

P/B (x)

0.00x

1.60x

1.18x

0.86x

Dividend Yield %

0.00%

1.07%

0.62%

0.85%

0.00x

5.59x

14.40x

25.07x

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

62.13

62.24

0.80

0.88

0.86

1.00

0.84

0.60

0.58

0.57

1.67

1.63

1.64

1.65

1.63

Government

0.00

35.40

35.35

35.37

35.11

35.26

35.50

35.52

35.56

Albert David Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Albert David Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI